This week is full of news relevant to those of us concerned about the future of antibiotics. The pharmaceutical industry is rebelling against the US plan to have Medicare negotiate drug prices.
Paratek
In December, BARDA (the Biomedical Advanced Research and Development Authority, which is part of HHS)